Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,080,733

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,080,733 protect, and when does it expire?

Patent 10,080,733 protects VUMERITY and is included in one NDA.

This patent has forty-six patent family members in twenty-five countries.

Summary for Patent: 10,080,733

Title:	Prodrugs of fumarates and their use in treating various diseases
Abstract:	The present invention provides compounds of formula (I), and pharmaceutical compositions thereof. ##STR00001##
Inventor(s):	Zeidan; Tarek A. (Lexington, MA), Duncan; Scott (Bedford, MA), Hencken; Christopher P. (Boston, MA), Wynn; Thomas Andrew (Lexington, MA), Sanrame; Carlos N. (Lexington, MA)
Assignee:	Alkermes Pharma Ireland Limited (Dublin, IE)
Application Number:	15/782,128
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,080,733
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Drugs Protected by US Patent 10,080,733

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Biogen Inc	VUMERITY	diroximel fumarate	CAPSULE, DELAYED RELEASE;ORAL	211855-001	Oct 29, 2019		RX	Yes	Yes	⤷ Try it Free	⤷ Try it Free	Y	Y		METHOD OF TREATING MULTIPLE SCLEROSIS	⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 10,080,733

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014239641	⤷ Try it Free
Australia	2016222363	⤷ Try it Free
Australia	2018200497	⤷ Try it Free
Brazil	112015022854	⤷ Try it Free
Canada	2906580	⤷ Try it Free
Canada	2992211	⤷ Try it Free
Canada	3081513	⤷ Try it Free
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

McKinsey

Medtronic

Boehringer Ingelheim

McKesson

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.